Literature DB >> 2168983

Structure-function studies of the herpes simplex virus type 1 DNA polymerase.

M L Haffey1, J Novotny, R E Bruccoleri, R D Carroll, J T Stevens, J T Matthews.   

Abstract

The analysis of the deduced amino acid sequence of the herpes simplex virus type 1 (HSV-1) DNA polymerase reported here suggests that the polymerase structure consists of domains carrying separate biological functions. The HSV-1 enzyme is known to possess 5'-3'-exonuclease (RNase H), 3'-5'-exonuclease, and DNA polymerase catalytic activities. Sequence analysis suggests an arrangement of these activities into distinct domains resembling the organization of Escherichia coli polymerase I. In order to more precisely define the structure and C-terminal limits of a putative catalytic domain responsible for the DNA polymerization activity of the HSV-1 enzyme, we have undertaken in vitro mutagenesis and computer modeling studies of the HSV-1 DNA polymerase gene. Sequence analysis predicts that the major DNA polymerization domain of the HSV-1 enzyme will be contained between residues 690 and 1100, and we present a three-dimensional model of this region, on the basis of the X-ray crystallographic structure of the E. coli polymerase I. Consistent with these structural and modeling studies, deletion analysis by in vitro mutagenesis of the HSV-1 DNA polymerase gene expressed in Saccharomyces cerevisiae has confirmed that certain amino acids from the C terminus (residues 1073 to 1144 and 1177 to 1235) can be deleted without destroying HSV-1 DNA polymerase catalytic activity and that the extreme N-terminal 227 residues are also not required for this activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168983      PMCID: PMC247992          DOI: 10.1128/JVI.64.10.5008-5018.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.

Authors:  D M Coen; H E Fleming; L K Leslie; M J Retondo
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP.

Authors:  D L Ollis; P Brick; R Hamlin; N G Xuong; T A Steitz
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  A program for prediction of protein secondary structure from nucleotide sequence data: application to histocompatibility antigens.

Authors:  J Novotný; C Auffray
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Primary structure of bacteriophage M2 DNA polymerase: conserved segments within protein-priming DNA polymerases and DNA polymerase I of Escherichia coli.

Authors:  K Matsumoto; H Takano; C I Kim; H Hirokawa
Journal:  Gene       Date:  1989-12-14       Impact factor: 3.688

7.  Properties of herpes simplex virus type 1 and type 2 DNA polymerase.

Authors:  M Ostrander; Y C Cheng
Journal:  Biochim Biophys Acta       Date:  1980-09-19

8.  Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.

Authors:  D Derse; K F Bastow; Y Cheng
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

9.  Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae.

Authors:  M Johnston; R W Davis
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

10.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

View more
  14 in total

Review 1.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

2.  Conformational changes induced in herpes simplex virus DNA polymerase upon DNA binding.

Authors:  K Weisshart; A A Kuo; G R Painter; L L Wright; P A Furman; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

3.  Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity.

Authors:  D J Tenney; P A Micheletti; J T Stevens; R K Hamatake; J T Matthews; A R Sanchez; W W Hurlburt; M Bifano; M G Cordingley
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  Sequences at the C-terminus of the herpes simplex virus type 1 UL30 protein are dispensable for DNA polymerase activity but not for viral origin-dependent DNA replication.

Authors:  N D Stow
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

Review 5.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

6.  Herpes Simplex Virus 1 DNA Polymerase RNase H Activity Acts in a 3'-to-5' Direction and Is Dependent on the 3'-to-5' Exonuclease Active Site.

Authors:  Jessica L Lawler; Purba Mukherjee; Donald M Coen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

7.  Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents.

Authors:  N S Lurain; K D Thompson; E W Holmes; G S Read
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.

Authors:  J K Wakefield; S A Jablonski; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Polymerization activity of an alpha-like DNA polymerase requires a conserved 3'-5' exonuclease active site.

Authors:  J S Gibbs; K Weisshart; P Digard; A deBruynKops; D M Knipe; D M Coen
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

10.  Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity.

Authors:  S A Jablonski; C D Morrow
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.